Mesenchymal stem cells in osteoarticular diseases.

Area of Science:

• Regenerative Medicine
• Immunology
• Rheumatology

Background:

• Mesenchymal stromal cells (MSCs) are multipotent cells primarily sourced from bone marrow and adipose tissue.
• Initially explored for tissue engineering due to their differentiation potential (bone, cartilage, fat).
• Increasing interest in MSCs for their immunomodulatory properties in clinical trials for graft-versus-host and autoimmune diseases.

Purpose of the Study:

• To explore the therapeutic mechanisms of MSCs in rheumatology.
• To highlight the potential of MSCs in promoting tissue repair and reducing inflammation in rheumatic conditions.
• To discuss innovative future strategies utilizing MSCs in rheumatology.

Main Methods:

• Review of existing literature on MSCs in tissue engineering and immunology.
• Analysis of MSC-mediated immunomodulation through soluble mediators.
• Focus on clinical applications and therapeutic potential in rheumatic diseases.

Main Results:

• MSCs possess multilineage differentiation capacity.
• MSC-mediated immunomodulation is achieved via secreted soluble factors.
• Clinical trials indicate MSCs' role in modulating immune responses.

Conclusions:

• MSCs offer therapeutic potential in rheumatology by promoting tissue regeneration and preventing inflammation.
• Understanding MSC mechanisms is key to developing innovative treatments for rheumatic diseases.
• Further research into MSC-based strategies holds promise for future rheumatological therapies.